Skip to main content
Quest Diagnostics

Highly Accurate Detection of Circulating Tumor DNA for Monitoring Minimal Residual Disease in Solid Tumors: Analytical and Clinical Validation of the Haystack MRD Assay

Highly Accurate Detection of Circulating Tumor DNA for Monitoring Minimal Residual Disease in Solid Tumors: Analytical and Clinical Validation of the Haystack MRD Assay

Authors: Clark M, Prathapam R, Bramlett KS, Helfrich-Kröger A, Sussman RT, Hwang HJ, Querfurth R, Champion KJ, Holtrup F, Slavin TP, Küntzlin-Schierloh D, Koenig A, Frame IJ, Maramica I, Quinn H, Kaplan JB, Mehnert DH, Sass C, Cleveland CL, Elzinga C, DeGrazia J, Angeloni T, Goos-Root D, Powers S, Carbonell JI, Stirzaker R, Debrincat MA, Chapman M, Brown E, Ryder M, Gibbs P, Sloane HS, Edelstein D, Tie J

Citation: J Mol Diagn. 2026 Aug 20:S1525-1578(26)00142-X. doi: 10.1016/j.jmoldx.2026.07.006. Online ahead of print.

Specialties: Oncology

Related content

Audio Podcast
Enhancing Cancer Treatment Decisions With Ultrasensitive MRD Testing
Test FAQ
Haystack MRD Testing
Publication
NGS defined measurable residual disease MRD after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia
Publication
Tracking Response to Neoadjuvant Systemic Therapy Through Circulating Tumor DNA Analysis in Breast Cancer
Publication
Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans
Publication
Analytical Validation of Blood-Derived Tumor Mutation Burden (bTMB) Assays: A Joint Consensus Recommendation of the BLOODPAC bTMB Analytical Validation Working Group
Test FAQ
Solid TumorSEQ

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.